SCOPUS 정보 검색 플랫폼

Volumn 24, Issue 5, 2003, Pages 219-228

Effect of length of sampling schedule and washout interval on magnitude of drug carryover from period 1 to period 2 in two-period, two-treatment bioequivalence studies and its attendant effects on determination of bioequivalence

(2) Dhariwal, Kuldeep b Jackson, Andre a

a CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

b NONE

Author keywords

AUC; Bioequivalence; Carryover; Washout interval

Indexed keywords

AMIODARONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARTMENT MODEL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MONTE CARLO METHOD; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIMULATION; STATISTICAL ANALYSIS; TIME;

ADOLESCENT; ADULT; AMIODARONE; AREA UNDER CURVE; COMPUTER SIMULATION; CROSS-OVER STUDIES; HALF-LIFE; HUMANS; MALE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PROBABILITY; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 0041663518 PISSN: 01422782 EISSN: None Source Type: Journal
DOI: 10.1002/bdd.359 Document Type: Article

Times cited : (12)

References (9)

1
- 51249087665
- Marcel Dekker: New York
- Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker: New York 1992; 30: 50.
- (1992) Design and Analysis of Bioavailability and Bioequivalence Studies , vol.30 , pp. 50
- Chow, S.C.¹ Liu, J.P.²

2
- 0003455042
- Food and Drug Administration, October 27
- Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. Food and Drug Administration, October 27, 2000.
- (2000) Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations

3
- 0004061014
- 1982. 2nd edn Marcel Dekker: New York
- Gibaldi M, Perrier D. 1982. Pharmacokinetics, 2nd edn Marcel Dekker: New York, 1982; 5: 297.
- (1982) Pharmacokinetics , vol.5 , pp. 297
- Gibaldi, M.¹ Perrier, D.²

4
- 0004239474
- Wiley: New York
- Cox DR. Planning of Experiments. Wiley: New York, 1958.
- (1958) Planning of Experiments
- Cox, D.R.¹

5
- 0004236701
- Wiley: New York
- Cochran WG, Cox MG. Experimental Designs. Wiley: New York, 1957.
- (1957) Experimental Designs
- Cochran, W.G.¹ Cox, M.G.²

6
- 0018987266
- The crossover experiment for clinical trials
- Brown BW. The crossover experiment for clinical trials. Biometrics 1980; 36: 69-79.
- (1980) Biometrics , vol.36 , pp. 69-79
- Brown, B.W.¹

7
- 0033555874
- Sample size determination for proving equivalence based on the ratio of two means for normally distributed data
- Hauschke D, Kieser M, Dilettli E, Burke M. Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Stat Med 1999; 18: 93-105.
- (1999) Stat. Med. , vol.18 , pp. 93-105
- Hauschke, D.¹ Kieser, M.² Dilettli, E.³ Burke, M.⁴

8
- 0032959595
- Use of truncated areas to measure extent of drug absorption in bioequivalence studies: Effects of drug absorption rate and elimination rate variability on this metric
- Kharidia J, Jackson AJ, Ouderkirk LA. Use of truncated areas to measure extent of drug absorption in bioequivalence studies: Effects of drug absorption rate and elimination rate variability on this metric. Pharm Res 16: 130-134.
- Pharm. Res. , vol.16 , pp. 130-134
- Kharidia, J.¹ Jackson, A.J.² Ouderkirk, L.A.³

9
- 0043111421
- Drug Intelligence Publications: Hamilton, IL
- Wagner JG. Fundamentals of Clincal Pharmacokinetics. Drug Intelligence Publications: Hamilton, IL.
- Fundamentals of Clincal Pharmacokinetics
- Wagner, J.G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.